Cancer cell attacked by Lymphocytes

Improving Immuno-Oncology Research Using Spatial Phenomics

In this GEN and IPM webinar, sponsored by Ultivue, our distinguished presenter, Dr. Keith Wharton, will discuss the utility of advanced multiplexing techniques to provide the much-needed insight affording a comprehensive study of cellular composition, cellular functions, and cell-cell interactions within the tumor microenvironment.
Adeno-associated viruses, illustration

Rapid QC Assessment of AAV Viral Vectors with Stunner

In this GEN webinar, sponsored by Unchained Labs, we’ll examine data generated from Stunner from multiple AAV samples generated from at-scale manufacturing campaigns at Vigene Biosciences (now a Charles River Laboratories company).
Natural Killer Cell (NK Cell) destroying a cancer cell

Spatial Phenotyping of the Tumor Microenvironment for Characterizing Tertiary Lymphoid Structures

In this GEN webinar, sponsored by Akoya, our distinguished presenter, Dr. Karen Willard-Gallo from Institut Jules Bordet, will share her study findings on TLS, T follicular helper cells (Tfh), and B cells in human breast cancer.
Adeno-associated viruses, 3D illustration

Gene Therapy: Meeting and Exceeding Regulatory Testing Requirements for AAV Vectors

In this GEN webinar, sponsored by WuXi, our distinguished presenters, Dr. Heather Malicki and Dr. Andreas Solomos will discuss the regulatory requirements and challenges involved with bringing new AAV-based gene therapies to market.
RNA viruses mutation, a mutation a an alteration in the sequence of the genome

Amplifying the Future of Vaccine Development with saRNA

In TOMORROW's GEN webinar, sponsored by Precision NanoSystems, our distinguished speaker, Dr. Ethan Settembre, will introduce us to the intricacies of saRNA and how it elicits immune responses. Moreover, he will describe the differences between saRNA vs. mRNA, how saRNA can be applied to generate influenza and COVID-19 vaccines, and why it may represent the future of RNA therapeutic development.